Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Boston Scientific
(NY:
BSX
)
48.33
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
48.33
Bid (Size)
47.79 (1)
Ask (Size)
49.37 (2)
Prev. Close
48.33
Today's Range
48.33 - 48.33
52wk Range
34.98 - 49.22
Shares Outstanding
1,423,852,648
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Can Healthcare Stocks Survive Macro Headwinds?
March 27, 2023
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year.
Via
Talk Markets
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
March 21, 2023
Via
Investor Brand Network
Performance
YTD
+5.04%
+5.04%
1 Month
+3.23%
+3.23%
3 Month
+4.52%
+4.52%
6 Month
+25.99%
+25.99%
1 Year
+9.17%
+9.17%
More News
Read More
Looking Into Boston Scientific's Recent Short Interest
March 10, 2023
Via
Benzinga
BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX
February 17, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
8 Analysts Have This to Say About Boston Scientific
February 02, 2023
Via
Benzinga
Why Boston Scientific Shares Are Trading Higher Today
February 01, 2023
Via
Benzinga
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
February 01, 2023
Via
Benzinga
A Preview Of Boston Scientific's Earnings
January 31, 2023
Via
Benzinga
4 Analysts Have This to Say About Boston Scientific
December 08, 2022
Via
Benzinga
What 4 Analyst Ratings Have To Say About Boston Scientific
December 08, 2022
Via
Benzinga
Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report
February 01, 2023
Via
Investor's Business Daily
GE Healthcare Technology: Speculating On Dividends
January 30, 2023
Via
MarketBeat
BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX
January 23, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects
January 19, 2023
Via
Benzinga
Expert Ratings for Boston Scientific
December 08, 2022
Via
Benzinga
Boston Scientific's Return on Invested Capital Insights
December 02, 2022
Via
Benzinga
Earnings Scheduled For February 1, 2023
February 01, 2023
Via
Benzinga
How Doug Godshall Ignited The Spark At Shockwave
January 12, 2023
Via
Investor's Business Daily
Is Medtronic Stock Ready to Revive?
January 09, 2023
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Supply Chain
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
Via
Benzinga
2 Smartest Tech Stocks to Buy in 2022 and Beyond
December 20, 2022
Via
The Motley Fool
Week In Review: Boston Scientific Pays $523 Million For Majority Stake In Beijing Acotec Scientific
December 17, 2022
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2022
Via
Benzinga
Stocks To Eye This Week
December 11, 2022
Via
Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
December 05, 2022
From
Brodsky & Smith LLC
Via
Globe NewsWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.